Verubecestat pharmacokinetic and exposure-response results from epoch: a phase 3 trial in mild-to-moderate alzheimer’s diseaseJulie A. Stone,Huub Jan Kleijn,David J. Jaworowicz,Marissa Dockendorf,Ming Xu,Christian Rasmussen,Rebecca Humphrey,Tiffini Voss,Mike F. EganAlzheimers & Dementia(2018)引用 0|浏览44暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要